Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Overcoming Immune Barriers to Stem Cell-Derived Beta Cell Transplantation | Grant | $199,999.98 | Research | Deepta Bhattacharya | Immunobiology | The New York Stem Cell Foundation | 05/2020 |
| Novel Gene Based Therapy for Nemaline Myopathy | Grant | $88,792.00 | Research | Hendrikus Granzier | Cellular & Molecular Medicine | Hospital for Sick Children (Canada) | 05/2020 |
| NRG Oncology NCORP Research Base | Cooperative Agreement | $144,704.00 | Research | Cynthia Thomson | Cancer Center Division | NRG Oncology | 05/2020 |
| Meaningful Drug-Drug Interactions Alerts | Grant | $21,071.00 | Research | Sheila Gephart | College of Nursing | University of Utah | 05/2020 |
| Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Severe Influenza Associated Illness in US Children | Contract | $44,500.00 | Research | Mary Gaspers | Pediatrics | Boston Children's Hospital | 05/2020 |
| Hemolysis and Free Heme Signaling in Pulmonary Hypertension | Grant | $2,071,020.00 | Research | Ruslan Rafikov | Medicine | National Heart, Lung, and Blood Institute | 05/2020 |
| Epigenetic Evaluation of WUI Firefighters | Contract | $380,478.00 | Research | Jefferey Burgess | Community Environment & Policy | Bureau Veritas North America | 05/2020 |
| Enhanced Mitochondrial Function to Increase Effectiveness of Post-Stroke Rehabilitation (IPA for Helena Morrison) | Contract | $37,164.14 | Research | Rick Schnellmann | Pharmacy Administration | United States Department of Veterans Affairs | 05/2020 |
| Endometriosis, Infertility, and Risk of Stroke | Grant | $442,205.00 | Research | Leslie Farland | Epidemiology and Biostatistics | Eunice Kennedy Shriver National Institute of Child Health and Human Development | 05/2020 |
| Development of Amygdalo-Prefrontal Connections in Adolescent Macaques | Grant | $1,151,246.00 | Research | Katalin Gothard | Physiology | National Institute of Mental Health | 05/2020 |
| Arrest Respiratory Failure Due to Pneumonia (ARREST PNEUMONIA) | Cooperative Agreement | $458,244.00 | Research | Christian Bime | Medicine | Stanford University | 05/2020 |
| Applied Research to Address the Coronavirus (COVID-19) Emerging Public Health Emergency | Contract | $10,000.00 | Research | Jefferey Burgess | Community Environment & Policy | Abt Associates | 05/2020 |
| Coronavirus State Hospital Improvement Program | Grant | $1,349,072.00 | Other Sponsored Activity | Leila Barraza | Community Environment & Policy | Health Resources and Services Administration | 05/2020 |
| Training Long Term - Pediatric Pulmonary Centers | Grant | $1,700,000.00 | Instruction | Cori Daines | Pediatrics | Health Resources and Services Administration | 05/2020 |
| Phase 1 Study of VE800 and Nivolumab in Patients with Selected Types of Advanced or Metastatic Cancer | Contract | $323,394.75 | Clinical Trial | Hani Babiker | Cancer Center Division | Vedanta Biosciences, Inc. | 05/2020 |
| Disease Morphology Image Study Protocol: A Retrospective, Multicenter, Data collection study for information about the disease morphology and stent restenosis patterns in the Iliac and SFA arteries, w | Contract | $17,187.52 | Clinical Trial | Kresimira Milas | Surgery | Bard Peripheral Vascular, Inc. | 05/2020 |
| A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately | Contract | $395,132.40 | Clinical Trial | Sasha Taleban | Medicine | PPD Investigator Services, LLC. | 05/2020 |
| A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma (TRYbeCA-1 - TRial of ErYaspase | Contract | $664,687.53 | Clinical Trial | Hani Babiker | Cancer Center Division | PPD Investigator Services, LLC. | 05/2020 |
| A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic... | Contract | $297,912.00 | Clinical Trial | Rachna Shroff | Cancer Center Division | Covance, Incorporated | 05/2020 |
| A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial To Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to.... | Contract | $124,499.00 | Clinical Trial | Mohamed Ahmed | Pediatrics | Pfizer, Incorporated | 05/2020 |
| A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of VX-814 in PiZZ Subjects | Contract | $79,672.00 | Clinical Trial | Ramachandra Sista | COM Phx Internal Medicine | Vertex Pharmaceuticals, Incorporated | 05/2020 |
| A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants with Previously Treated Locally Advanced/Metastatic or Surgically Unresectable.. | Contract | $171,440.00 | Clinical Trial | Aaron Scott | Cancer Center Division | Incyte Corporation | 05/2020 |
| A Phase 2 Open-Label Study of Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-cell Lymphoma (PTCL) in Adults Age 60 and Above | Contract | $147,691.00 | Clinical Trial | Daniel Persky | Cancer Center Division | Seattle Genetics, Incorporated | 05/2020 |
| Total Worker Health for Wildland Firefighters | Grant | $74,540.00 | Research | Jefferey Burgess | Community Environment & Policy | Oregon Health and Science University | 04/2020 |
| Contract | $231,030.00 | Clinical Trial | Steve Chung | COM Phx Neurology | NCGS Incorporated | 03/2020 |